More News – Page 88
-
NewsFA Bio licenses two microbes to IFF’s Crop Biologicals division to advance microbial solutions for crop health
FA Bio, a leader in the discovery of sustainable agricultural products, has extended a license agreement on two microbials to IFF’s Crop Biologicals business.
-
NewsResearch team publishes paradigm-challenging discovery in a Yellowstone thermophile
A graduating PhD student has made an interesting discovery about a common thermophilic bacteria dwelling in hots prings which is able to simultaneously respirate and metabolize via aerobic and anaerobic pathways.
-
NewsNew discovery and grant to accelerate Strep A vaccine efforts
With a large sum of research funding and multinational contributions, the world’s only Strep A human challenge model will be used to resolve logistical issues and speed up the development of a successful Strep A vaccine.
-
NewsNovel enzyme found in gut bacteria could revolutionize prebiotic research
Researchers have discovered a new β-galactosidase enzyme in a human gut bacterium that breaks down and synthesizes previously unexplored glycans, which have prebiotic capabilities to improve gut health.
-
NewsDermatophytes adaptation to the human host exemplified by Microsporum canis
Through comparative genomic analyses, researchers investigated the evolutionary mechanisms that underpin gene expansions to enable dermatophytes, such as Microsporum canis to transition from animal to human hosts.
-
NewsGreat whale pee funnel carries nutrients thousands of miles, boosting phytoplanktons
A new study shows that whales carry huge quantities of nutrients horizontally, across whole ocean basins, from rich, cold waters where they feed to warm shores near the equator where they mate and give birth.
-
NewsBacteria and minerals work together to detoxify arsenic in contaminated soils
New research shows that the interaction between arsenic-oxidizing bacteria and goethite, a common Fe mineral, significantly accelerates the conversion of arsenic from its highly toxic form, arsenite [As(III)], into the less harmful arsenate [As(V)].
-
NewsEarly-life gut microbes may protect against diabetes, research in mice suggests
A research discovered that the colonization of a fungus called <i>Candida dubliniensis</i> in the early life gut microbiome of mice, is able to promote growth of pancreatic beta cells in the presence of macrophages to restore blood insulin level and improve metabolic functions, thus reducing risks of type 1 diabetes.
-
NewsSulfur-reducing bacteria team-up to break down organic substances in the seabed
Researchers have decoded the molecular strategies employed by the underappreciated sulfate-reducing bacteria, <i>Desulfobacteraceae</i>, which is capable of breaking down organic carbon in the oxygen-limited seabed.
-
NewsOncomicrobial vaccines mitigate tumor progression by precisely targeting oncomicrobes in mice
Oncomicrobial vaccines targeting C. jejuni and ETBF can effectively reduce the colonization of these cancer-promoting microbes, suppress tumor development, and mitigate inflammation in mouse models, according to a new study.
-
NewsPurified immunoglobulin F(ab′) 2 prevents lethal staphylococcal enterotoxin B intoxication in mice and rhesus monkeys
Purified F(ab′)2 fragments are an effective antidote to lethal SEB doses in mice and rhesus monkeys, and therefore might be a favorable candidate for treating patients with severe SEB intoxication, a new study suggests.
-
NewsScientists develop low-cost handheld sensor test for airborne bird flu
Researchers have developed a prototype sensor that detects a virus that causes bird flu (H5N1) in air samples. The low-cost handheld sensor detects the virus at levels below an infectious dose and could lead to rapid aerosol testing for airborne avian influenza.
-
NewsTranscription factor PoMbp1 promotes the growth of Pleurotus ostreatus by regulating polysaccharide utilisation
A study investigating the growth and development of Pleurotus ostreatus has found that PoMbp1 contains an APSES domain and localizes to the nucleus, indicating it belongs to the fungal-specific APSES transcription factors family.
-
NewsAntimicrobial resistance in soil bacteria without the use of antibiotics
Overuse of antibiotics is currently the primary reason for the rise of antimicrobial resistance (AMR), but researchers have shown that AMR can be found in soil bacterial communities due to microbial interactions too, driven by a species of predatory bacteria.
-
NewssiRNA-AGO2 complex inhibits bacterial gene translation: a novel therapeutic strategy for superbug infection
Scientists have demonstrated that exosomes can serve as delivery vehicles to introduce AGO2-loaded siRNA into the cytoplasm of bacteria, and in turn down-regulated gene expression of the mRNA that shares sequence complementarity to the siRNA.
-
NewsScietnists probe Rhytismataceae on twigs of Rhododendron
Following a study of fungal specimens collected from the twigs of Rhododendron species in China, three new genera were proposed and 21 species residing in 11 genera of Rhytismataceae were delimited, which include 18 new species and three new combinations.
-
NewsEffects of electroacupuncture combined with Chinese herbal medicine on gut microbiota and metabolomics in amyotrophic lateral sclerosis
Studies have highlighted a link between amyotrophic lateral sclerosis (ALS) and gut microbiota. A prospective study aimed to evaluate the effects of electroacupuncture combined with Chinese herbal medicine on gut microbiota and metabolomics in ALS patients.
-
NewsThe Institut Pasteur joins the Stand Up for Science community
Echoing the Stand Up for Science Day initiated in the United States, scientists and academics in France are calling for mobilization actions in every city.
-
NewsNovel insights into Candida glabrata in pregnant women’s reproductive tracts in Hainan
A study of Candida glabrata in pregnant women with vaginal discomfort at Haikou Maternal and Child Health Hospital found that 64.5% of the 594 yeast isolates (383 isolates) showed resistance (R) or intermediate (I) phenotypes to at least one of four commonly used antifungals.
-
NewsEradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25.